Related Experiment Video
Updated: Sep 17, 2025

Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung
Published on: January 22, 2021
Antibacterial Properties of Nonsteroidal Anti-inflammatory Drugs and Proton Pump Inhibitors Against Enterococcus
Sufia Parveen1, Navin Mishra2, Md Jawed Akhtar3
1Department of Conservative Dentistry and Endodontics, Buddha Institute of Dental Sciences and Hospital, Patna, IND.
Abstract:
Background Enterococcus faecalis is a common cause of persistent endodontic infections due to its resistance to conventional treatments. While triple antibiotic paste (TAP) is effective, concerns about antibiotic resistance have led to interest in nonantibiotic alternatives. Nonsteroidal anti-inflammatory medications (NSAIDs) and proton pump inhibitors (PPIs) have shown promising antibacterial activity. This study aimed to compare the efficacy of diclofenac sodium (DS), TAP, and their combinations with pantoprazole against E. faecalis in vitro. Methodology This in vitro study evaluated the antibacterial efficacy of DS, TAP, and pantoprazole (a PPI), both individually and in combination, against E. faecalis (ATCC 29212). Standardized bacterial suspensions were tested using the agar well diffusion method on Mueller-Hinton agar plates. A total of 140 plates were divided across five groups to assess the antimicrobial zones of inhibition. Test compounds were freshly prepared and introduced into wells under aseptic conditions, followed by incubation at 37°C for 24 hours. Inhibition zones were measured digitally in mm, and data were statistically analyzed using analysis of variance and t-tests, with significance set at p-values <0.05. Results In this study, TAP exhibited the highest antibacterial activity among the standard drugs, followed by DS, while PPI showed the least efficacy. However, when combined with PPI, both TAP and DS demonstrated significantly enhanced zones of inhibition against E. faecalis, with the TAP + PPI group showing the greatest effect (40.05 ± 0.91 mm), followed by DS + PPI (37.06 ± 0.90 mm). These differences were statistically significant (p < 0.0001), indicating a synergistic benefit from combining PPI with either TAP or DS. Conclusions The combination of TAP + PPI showed the highest antibacterial efficacy against E. faecalis, followed by DS + PPI, TAP, DS, and PPI alone. Drug combinations demonstrated significantly greater inhibition zones compared to individual agents, indicating enhanced antimicrobial activity.
More Related Videos
09:39A Platform of Anti-biofilm Assays Suited to the Exploration of Natural Compound Libraries
Published on: December 27, 2016
11:59Isolation of Lipoprotein Particles from Chicken Egg Yolk for the Study of Bacterial Pathogen Fatty Acid Incorporation into Membrane Phospholipids
Published on: May 15, 2019
Related Concept Videos
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Development of Antibiotic Resistance
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists